Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study

V. D. Palumbo, M. Romeo, A. Marino Gammazza, F. Carini, P. Damiani, G. Damiano, S. Buscemi, A. I. Lo Monte, A. Gerges-Geagea, A. Jurjus, G. Tomasello

. 2016 ; 160 (3) : 372-377. [pub] 20160913

Language English Country Czech Republic

Document type Journal Article, Randomized Controlled Trial

Persistent link   https://www.medvik.cz/link/bmc17016662

AIM: Intestinal dysbiosis seems to be the leading cause of inflammatory bowel diseases, and probiotics seems to represent the proper support against their occurrence. Actually, probiotic blends and anti-inflammatory drugs represent a weapon against inflammatory bowel diseases. The present study evaluates the long-term (2 years) effects of combination therapy (mesalazine plus a probiotic blend of Lactobacillus salivarius, Lactobacillus acidophilus and Bifidobacterium bifidus strain BGN4) on ulcerative colitis activity. METHOD: Sixty patients with moderate-to-severe ulcerative colitis were enrolled: 30 of them were treated with a single daily oral administration of mesalazine 1200 mg; 30 patients received a single daily oral administration of mesalazine 1200 mg and a double daily administration of a probiotic blend of Lactobacillus salivarius, Lactobacillus acidophilus and Bifidobacterium bifidus strain BGN4. The treatment was carried out for two years and the clinical response evaluated according to the Modified Mayo Disease Activity Index. RESULTS: All patients treated with combination therapy showed better improvement compared to the controls. In particular, the beneficial effects of probiotics were evident even after two years of treatment. CONCLUSIONS: A long-term treatment modality of anti-inflammatory drugs and probiotics is viable and could be an alternative to corticosteroids in mild-to moderate ulcerative colitis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17016662
003      
CZ-PrNML
005      
20170519133136.0
007      
ta
008      
170516s2016 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2016.044 $2 doi
035    __
$a (PubMed)27623957
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Palumbo, Vincenzo Davide $u Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy; Department of Surgical, Oncological and Stomatological Disciplines, School of Medicine, University of Palermo, Palermo, Italy
245    14
$a The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study / $c V. D. Palumbo, M. Romeo, A. Marino Gammazza, F. Carini, P. Damiani, G. Damiano, S. Buscemi, A. I. Lo Monte, A. Gerges-Geagea, A. Jurjus, G. Tomasello
520    9_
$a AIM: Intestinal dysbiosis seems to be the leading cause of inflammatory bowel diseases, and probiotics seems to represent the proper support against their occurrence. Actually, probiotic blends and anti-inflammatory drugs represent a weapon against inflammatory bowel diseases. The present study evaluates the long-term (2 years) effects of combination therapy (mesalazine plus a probiotic blend of Lactobacillus salivarius, Lactobacillus acidophilus and Bifidobacterium bifidus strain BGN4) on ulcerative colitis activity. METHOD: Sixty patients with moderate-to-severe ulcerative colitis were enrolled: 30 of them were treated with a single daily oral administration of mesalazine 1200 mg; 30 patients received a single daily oral administration of mesalazine 1200 mg and a double daily administration of a probiotic blend of Lactobacillus salivarius, Lactobacillus acidophilus and Bifidobacterium bifidus strain BGN4. The treatment was carried out for two years and the clinical response evaluated according to the Modified Mayo Disease Activity Index. RESULTS: All patients treated with combination therapy showed better improvement compared to the controls. In particular, the beneficial effects of probiotics were evident even after two years of treatment. CONCLUSIONS: A long-term treatment modality of anti-inflammatory drugs and probiotics is viable and could be an alternative to corticosteroids in mild-to moderate ulcerative colitis.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a antiflogistika nesteroidní $x terapeutické užití $7 D000894
650    _2
$a Bifidobacterium bifidum $7 D000069985
650    _2
$a ulcerózní kolitida $x farmakoterapie $7 D003093
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a Lactobacillus acidophilus $7 D007779
650    _2
$a Lactobacillus salivarius $7 D000069996
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mesalamin $x terapeutické užití $7 D019804
650    _2
$a lidé středního věku $7 D008875
650    _2
$a probiotika $x terapeutické užití $7 D019936
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Romeo, Marcello $u Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy
700    1_
$a Marino Gammazza, Antonella $u Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy; Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy
700    1_
$a Carini, Francesco $u Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy; P. Giaccone University Hospital, Palermo, Italy
700    1_
$a Damiani, Provvidenza $u P. Giaccone University Hospital, Palermo, Italy
700    1_
$a Damiano, Giuseppe $u Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy
700    1_
$a Buscemi, Salvatore $u Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy
700    1_
$a Lo Monte, Attilio Ignazio $u Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy; P. Giaccone University Hospital, Palermo, Italy
700    1_
$a Gerges-Geagea, Alice $u Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy; Department of Anatomy, Cell Biology and Physiology, School of Medidcine, Aamerican University of Beirut, Beirut, Lebanon
700    1_
$a Jurjus, Abdo $u Department of Anatomy, Cell Biology and Physiology, School of Medidcine, Aamerican University of Beirut, Beirut, Lebanon
700    1_
$a Tomasello, Giovanni $u Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy; Department of Experimental Biomedicine and Clinical Neuroscience, School of Medicine, University of Palermo, Palermo, Italy; P. Giaccone University Hospital, Palermo, Italy
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 3 (2016), s. 372-377
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170516 $b ABA008
991    __
$a 20170517145502 $b ABA008
999    __
$a ok $b bmc $g 1205808 $s 977471
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 160 $c 3 $d 372-377 $e 20160913 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170516
Back

Find record

Citation metrics

Archiving options